Literature DB >> 30168616

Hepatitis B Virus-Specific T Cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.

Yongjun Tian1, Jing-Hsiung James Ou2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30168616      PMCID： PMC6393196          DOI： 10.1002/hep.30243

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

Review 1.  Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

Authors:  M-L Chang; Y-F Liaw; S J Hadziyannis
Journal:  Aliment Pharmacol Ther       Date:  2015-06-10       Impact factor: 8.171

2.  Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.

Authors:  Laura Rivino; Nina Le Bert; Upkar S Gill; Kamini Kunasegaran; Yang Cheng; Damien Zm Tan; Etienne Becht; Navjyot K Hansi; Graham R Foster; Tung-Hung Su; Tai-Chung Tseng; Seng Gee Lim; Jia-Horng Kao; Evan W Newell; Patrick Tf Kennedy; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

3.  Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission.

Authors:  Yongjun Tian; Cheng-Fu Kuo; Omid Akbari; Jing-Hsiung James Ou
Journal:  Immunity       Date:  2016-05-03       Impact factor: 31.745

4.  Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy.

Authors:  Heng Chi; Zhandong Li; Bettina E Hansen; Tao Yu; Xiaoyong Zhang; Jian Sun; Jinlin Hou; Harry L A Janssen; Jie Peng
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-11       Impact factor: 11.382

5.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Authors:  P Fisicaro; C Valdatta; C Boni; M Massari; C Mori; A Zerbini; A Orlandini; L Sacchelli; G Missale; C Ferrari
Journal:  Gut       Date:  2009-02-06       Impact factor: 23.059

6.  AASLD guidelines for treatment of chronic hepatitis B.

Authors:  Norah A Terrault; Natalie H Bzowej; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; M Hassan Murad
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

7.  Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells.

Authors:  Pamela M Odorizzi; Kristen E Pauken; Michael A Paley; Arlene Sharpe; E John Wherry
Journal:  J Exp Med       Date:  2015-06-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.